tiprankstipranks
PolyPeptide Group AG (CH:PPGN)
:PPGN
Switzerland Market
PPGN
PolyPeptide Group AG
RESEARCH TOOLSreports

PolyPeptide Group AG (PPGN) Financial Statements

1 Followers

PolyPeptide Group AG Financial Overview

PolyPeptide Group AG's market cap is currently CHF1.05B. The company's EPS TTM is CHF0.152; its P/E ratio is -43.40; PolyPeptide Group AG is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is CHF-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 391.87M€ 338.69M€ 320.37M€ 280.98M€ 282.13M
Gross Profit€ 64.32M€ 39.27M€ 4.77M€ 51.99M€ 99.70M
Operating Income€ 7.41M€ -7.36M€ -36.47M€ 12.61M€ 64.17M
EBITDA€ 44.42M€ 28.42M€ -22.15M€ 35.72M€ 83.35M
Net Income€ -21.31M€ -19.56M€ -51.44M€ 7.77M€ 47.26M
Balance Sheet
Cash & Short-Term Investments€ 74.53M€ 68.28M€ 95.71M€ 37.53M€ 136.30M
Total Assets€ 825.31M€ 756.58M€ 689.09M€ 575.78M€ 595.04M
Total Debt€ 130.46M€ 94.12M€ 113.66M€ 21.22M€ 18.00M
Net Debt€ 55.93M€ 25.84M€ 17.96M€ -16.31M€ -118.30M
Total Liabilities€ 484.98M€ 399.33M€ 307.86M€ 154.10M€ 173.87M
Stockholders' Equity€ 340.33M€ 357.24M€ 381.23M€ 421.68M€ 421.17M
Cash Flow
Free Cash Flow€ -30.44M€ 2.43M€ -20.25M€ -69.64M€ -16.61M
Operating Cash Flow€ 78.02M€ 89.40M€ 36.48M€ 5.46M€ 57.35M
Investing Cash Flow€ -112.44M€ -91.02M€ -59.51M€ -78.44M€ -80.84M
Financing Cash Flow€ 34.01M€ -25.32M€ 84.55M€ -26.87M€ 130.93M
Currency in EUR

PolyPeptide Group AG Earnings and Revenue History

Income Statement >

PolyPeptide Group AG Debt to Assets

Balance Sheet >

PolyPeptide Group AG Cash Flow

Cash Flow >

PolyPeptide Group AG Forecast EPS vs Actual EPS

Earnings >